0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
History of Medicine |

Clinical Trials That Have Influenced the Treatment of Venous Thromboembolism: A Historical Perspective

Jack Hirsh, MD, FRCP(C); and Shannon M. Bates, MDCM, FRCP(C)
[+] Article and Author Information

From Hamilton Civic Hospitals Research Centre and McMaster University, Hamilton, Ontario, Canada.


Acknowledgment: The authors thank Drs. J.S. Lawsen, J.I. Weitz, and M. Levine for critically reviewing the manuscript.

Disclaimer: Dr. Hirsh has received honoraria as a speaker and as a member or chairman of speaker panels for continuing medical education events from Aventis, Astra-Zeneca, Sanofi, Leo, Pharmacia & Upjohn, and DuPont; has received consulting fees from Conceptis, Aventis, and Astra-Zeneca; and owns stock in Glycodesign, a public glycobiology company. However, no Glycodesign product was mentioned in this paper. Dr. Bates has received honoraria as a speaker from Pharmacia & Upjohn.

Grant Support: Dr. Bates is the recipient of a Heart and Stroke Foundation of Ontario Research Fellowship.

Requests for Single Reprints: Jack Hirsh, MD, FRCP(C), Hamilton Civic Hospitals Research Centre, Henderson Division, 711 Concession Street, Hamilton, Ontario L8V 1C3, Canada; e-mail, jhirsh@thrombosis.hhscr.org.

Current Author Addresses: Dr. Hirsh: Hamilton Civic Hospitals Research Centre, Henderson Division, 711 Concession Street, Hamilton, Ontario L8V 1C3, Canada.

Dr. Bates: McMaster University Medical Centre, 1200 Main Street West, Hamilton, Ontario L8N 3Z5, Canada.


Ann Intern Med. 2001;134(5):409-417. doi:10.7326/0003-4819-134-5-200103060-00013
Text Size: A A A

In 1960, Barritt and Jordan performed the first randomized trial demonstrating the efficacy of anticoagulant therapy in the treatment of venous thromboembolism. Since then, important therapeutic advances have been made in the treatment of deep venous thrombosis and pulmonary embolism. This paper reviews the important clinical trials involving anticoagulant therapy and vena caval interruption. The studies are discussed from a historical perspective, and an attempt is made to analyze both the thought processes that prompted their design and the reasons why they changed practice.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Topic Collections
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)